Global Obesity Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Obesity Treatment Revenue
• 1.4 Market by Type
  • 1.4.1 Global Obesity Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Surgical & Implant Devices
  • 1.4.3 Medication Therapy
  • 1.4.4 Dietary
  • 1.4.5 Other
• 1.5 Market by Application
  • 1.5.1 Global Obesity Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Children
  • 1.5.3 Adults
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Obesity Treatment Market Perspective (2015-2026)
• 2.2 Global Obesity Treatment Growth Trends by Regions
  • 2.2.1 Obesity Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Obesity Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Obesity Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Obesity Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Obesity Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Obesity Treatment Players by Market Size
  • 3.1.1 Global Top Obesity Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Obesity Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Obesity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Obesity Treatment Market Concentration Ratio
  • 3.2.1 Global Obesity Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Obesity Treatment Revenue in 2019
• 3.3 Obesity Treatment Key Players Head office and Area Served
• 3.4 Key Players Obesity Treatment Product Solution and Service
• 3.5 Date of Enter into Obesity Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Obesity Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Obesity Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Obesity Treatment Market Size by Application (2015-2020)
• 5.2 Global Obesity Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Obesity Treatment Market Size (2015-2020)
• 6.2 Obesity Treatment Key Players in North America (2019-2020)
• 6.3 North America Obesity Treatment Market Size by Type (2015-2020)
• 6.4 North America Obesity Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Obesity Treatment Market Size (2015-2020)
• 7.2 Obesity Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Obesity Treatment Market Size by Type (2015-2020)
• 7.4 Europe Obesity Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Obesity Treatment Market Size (2015-2020)
• 8.2 Obesity Treatment Key Players in China (2019-2020)
• 8.3 China Obesity Treatment Market Size by Type (2015-2020)
• 8.4 China Obesity Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Obesity Treatment Market Size (2015-2020)
• 9.2 Obesity Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Obesity Treatment Market Size by Type (2015-2020)
• 9.4 Japan Obesity Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Obesity Treatment Market Size (2015-2020)
• 10.2 Obesity Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Obesity Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Obesity Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Obesity Treatment Market Size (2015-2020)
• 11.2 Obesity Treatment Key Players in India (2019-2020)
• 11.3 India Obesity Treatment Market Size by Type (2015-2020)
• 11.4 India Obesity Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Obesity Treatment Market Size (2015-2020)
• 12.2 Obesity Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Obesity Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Obesity Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 NutriSystem, Inc. (U.S.)
  • 13.1.1 NutriSystem, Inc. (U.S.) Company Details
  • 13.1.2 NutriSystem, Inc. (U.S.) Business Overview
  • 13.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Introduction
  • 13.1.4 NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2015-2020))
  • 13.1.5 NutriSystem, Inc. (U.S.) Recent Development
• 13.2 Kellogg Company (U.S.)
  • 13.2.1 Kellogg Company (U.S.) Company Details
  • 13.2.2 Kellogg Company (U.S.) Business Overview
  • 13.2.3 Kellogg Company (U.S.) Obesity Treatment Introduction
  • 13.2.4 Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 13.2.5 Kellogg Company (U.S.) Recent Development
• 13.3 Ethicon, Inc. (U.S.)
  • 13.3.1 Ethicon, Inc. (U.S.) Company Details
  • 13.3.2 Ethicon, Inc. (U.S.) Business Overview
  • 13.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Introduction
  • 13.3.4 Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 13.3.5 Ethicon, Inc. (U.S.) Recent Development
• 13.4 Medtronic (U.S.)
  • 13.4.1 Medtronic (U.S.) Company Details
  • 13.4.2 Medtronic (U.S.) Business Overview
  • 13.4.3 Medtronic (U.S.) Obesity Treatment Introduction
  • 13.4.4 Medtronic (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 13.4.5 Medtronic (U.S.) Recent Development
• 13.5 F. Hoffmann-La Roche (Switzerland)
  • 13.5.1 F. Hoffmann-La Roche (Switzerland) Company Details
  • 13.5.2 F. Hoffmann-La Roche (Switzerland) Business Overview
  • 13.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Introduction
  • 13.5.4 F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2015-2020)
  • 13.5.5 F. Hoffmann-La Roche (Switzerland) Recent Development
• 13.6 Atkins Nutritionals, Inc. (U.S.)
  • 13.6.1 Atkins Nutritionals, Inc. (U.S.) Company Details
  • 13.6.2 Atkins Nutritionals, Inc. (U.S.) Business Overview
  • 13.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Introduction
  • 13.6.4 Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 13.6.5 Atkins Nutritionals, Inc. (U.S.) Recent Development
• 13.7 Herbalife Ltd. (U.S.)
  • 13.7.1 Herbalife Ltd. (U.S.) Company Details
  • 13.7.2 Herbalife Ltd. (U.S.) Business Overview
  • 13.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Introduction
  • 13.7.4 Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 13.7.5 Herbalife Ltd. (U.S.) Recent Development
• 13.8 Covidien plc (U.S.)
  • 13.8.1 Covidien plc (U.S.) Company Details
  • 13.8.2 Covidien plc (U.S.) Business Overview
  • 13.8.3 Covidien plc (U.S.) Obesity Treatment Introduction
  • 13.8.4 Covidien plc (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 13.8.5 Covidien plc (U.S.) Recent Development
• 13.9 Apollo Endosurgery (U.S.)
  • 13.9.1 Apollo Endosurgery (U.S.) Company Details
  • 13.9.2 Apollo Endosurgery (U.S.) Business Overview
  • 13.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Introduction
  • 13.9.4 Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 13.9.5 Apollo Endosurgery (U.S.) Recent Development
• 13.10 Amer Sports (Finland)
  • 13.10.1 Amer Sports (Finland) Company Details
  • 13.10.2 Amer Sports (Finland) Business Overview
  • 13.10.3 Amer Sports (Finland) Obesity Treatment Introduction
  • 13.10.4 Amer Sports (Finland) Revenue in Obesity Treatment Business (2015-2020)
  • 13.10.5 Amer Sports (Finland) Recent Development
• 13.11 Johnson Health Technology, Ltd. (Taiwan)
  • 10.11.1 Johnson Health Technology, Ltd. (Taiwan) Company Details
  • 10.11.2 Johnson Health Technology, Ltd. (Taiwan) Business Overview
  • 10.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Introduction
  • 10.11.4 Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2015-2020)
  • 10.11.5 Johnson Health Technology, Ltd. (Taiwan) Recent Development
• 13.12 Cybex International (U.S.)
  • 10.12.1 Cybex International (U.S.) Company Details
  • 10.12.2 Cybex International (U.S.) Business Overview
  • 10.12.3 Cybex International (U.S.) Obesity Treatment Introduction
  • 10.12.4 Cybex International (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 10.12.5 Cybex International (U.S.) Recent Development
• 13.13 USGI Medical (U.S.)
  • 10.13.1 USGI Medical (U.S.) Company Details
  • 10.13.2 USGI Medical (U.S.) Business Overview
  • 10.13.3 USGI Medical (U.S.) Obesity Treatment Introduction
  • 10.13.4 USGI Medical (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 10.13.5 USGI Medical (U.S.) Recent Development
• 13.14 Olympus Corporation (Japan)
  • 10.14.1 Olympus Corporation (Japan) Company Details
  • 10.14.2 Olympus Corporation (Japan) Business Overview
  • 10.14.3 Olympus Corporation (Japan) Obesity Treatment Introduction
  • 10.14.4 Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2015-2020)
  • 10.14.5 Olympus Corporation (Japan) Recent Development
• 13.15 Brunswick Corporation (U.S.)
  • 10.15.1 Brunswick Corporation (U.S.) Company Details
  • 10.15.2 Brunswick Corporation (U.S.) Business Overview
  • 10.15.3 Brunswick Corporation (U.S.) Obesity Treatment Introduction
  • 10.15.4 Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2015-2020)
  • 10.15.5 Brunswick Corporation (U.S.) Recent Development
• 13.16 Technogym SpA (Italy)
  • 10.16.1 Technogym SpA (Italy) Company Details
  • 10.16.2 Technogym SpA (Italy) Business Overview
  • 10.16.3 Technogym SpA (Italy) Obesity Treatment Introduction
  • 10.16.4 Technogym SpA (Italy) Revenue in Obesity Treatment Business (2015-2020)
  • 10.16.5 Technogym SpA (Italy) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer